|
Real-time
Euronext Paris
13:48:32 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 319.50 EUR | +1.27% |
|
+3.73% | -10.63% |
| 09-28 | Virbac Announces Board and Committee Changes | CI |
| 09-18 | Virbac SA, H1 2026 Earnings Call, Sep 18, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.96B | |||||
| 1,043B | |||||
| 618B | - | ||||
| 481B | |||||
| 351B | |||||
| 338B |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
